Updated:
January 09, 2021 22:19 IST
With the daily cases coming down, many people who would have volunteered would not see the urgency now as earlier
Share Article
AAA
The alternative: Vaccine manufacturers can carry out phase-3 trials outside India and efficacy results from such trials would be accepted by the Indian regulator for vaccine approval.
| Photo Credit:
Irina Velichkina
With the daily cases coming down, many people who would have volunteered would not see the urgency now as earlier
On January 1, Pune-based Serum Institute’s Covishield vaccine was granted permission for restricted use, while Bharat Biotech’s Covaxin got a similar approval the next day with certain other riders. With two vaccines now being greenlighted for restricted use, the four high-risk priority groups, beginning with frontline health-care workers, will soon begin getting vaccinated. Nearly 300 million people belonging to the four priority groups are to be vaccinated with either of th
Covid 19: Firms may face problems in finding volunteers for vaccine trials in India - कोरोना वैक्सीन बनाने वाली कंपनियों को होने वाली हैं दिक्कतें, ट्रायल के लिए वॉलंटियर्स की हो सकती है कमी
livehindustan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livehindustan.com Daily Mail and Mail on Sunday newspapers.
nepal to prefer indian vaccine over chinese as nepali minister expect commitment for 12 million doses ahead new delhi visit : चीनी नहीं बल्कि पहले भारतीय वैक्सीन को तरजीह देगा नेपाल, बीजिंग की पेशकश के बाद भी भारत से चाहता है पक्का भरोसा
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Key learnings from the first Covid-19 vaccination dry-run The key learnings from the dry-run held earlier this week across four states were to map remote locations better, report adverse events in real-time, and ramp up training, according to a report in The Indian Express. Three issues were highlighted in the first dry run, according to the report. First, pin-codes from some villages were not mapped to the Co-Win platform, India s digital system that will track and monitor the vaccination programme. Second, “adverse events” could only be reported to the Co-Win platform after the end of an entire vaccination session – in this case, of 100 people. Third, at some sites, the five-member team did not know who was supposed to do what. These hiccups are expected to be sorted out in the second dry run underway today. Read more here